Company Reports

Found 27 publications
Zalicus Inc. – Product Pipeline Review – H2 2011 US$ 500.00 Sep, 2011 73 pages
ImmunoGen, Inc. – Product Pipeline Review – H2 2011 US$ 500.00 Sep, 2011 104 pages
Idera Pharmaceuticals, Inc. – Product Pipeline Review – H2 2011 US$ 500.00 Sep, 2011 69 pages
ARQULE, INC – Product Pipeline Review – H2 2011 US$ 500.00 Sep, 2011 79 pages
Ark Therapeutics Group plc – Product Pipeline Review – H2 2011 US$ 500.00 Sep, 2011 65 pages
Zalicus Inc. – Product Pipeline Review – Q2 2011 US$ 500.00 Jul, 2011 62 pages
Endo Pharmaceuticals Inc. – Product Pipeline Review – Q2 2011 US$ 500.00 Jul, 2011 32 pages
ImmunoGen, Inc. – Product Pipeline Review – Q2 2011 US$ 500.00 Jul, 2011 71 pages
Telik, Inc. – Product Pipeline Review – Q2 2011 US$ 500.00 Jul, 2011 35 pages
Taisho Pharmaceutical Co., Ltd. – Product Pipeline Review – Q2 2011 US$ 500.00 Jul, 2011 62 pages
Santen Pharmaceutical Co., Ltd. – Product Pipeline Review – Q2 2011 US$ 500.00 Jul, 2011 49 pages
Lexicon Pharmaceuticals, Inc. – Product Pipeline Review – Q2 2011 US$ 500.00 Jul, 2011 55 pages
Idera Pharmaceuticals, Inc. – Product Pipeline Review – Q2 2011 US$ 500.00 Jul, 2011 70 pages
Ark Therapeutics Group plc – Product Pipeline Review – Q2 2011 US$ 500.00 Jul, 2011 62 pages
Anavex Life Sciences Corp. – Product Pipeline Review – Q2 2011 US$ 500.00 Jul, 2011 43 pages
Alkermes, Inc. – Product Pipeline Review – Q2 2011 US$ 500.00 Jul, 2011 55 pages
MediciNova, Inc. – Product Pipeline Review – Q2 2011 US$ 500.00 Jul, 2011 48 pages
Salix Pharmaceuticals, Ltd. – Product Pipeline Review – Q2 2011 US$ 500.00 Jul, 2011 75 pages
QLT Inc. – Product Pipeline Review – Q2 2011 US$ 500.00 Jul, 2011 67 pages
Celldex Therapeutics, Inc. – Product Pipeline Review – Q2 2011 US$ 500.00 Jul, 2011 69 pages
1 2 >